Top Markets
#1 Bitway Bitway +55.99%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +39.20%
#3 Starpower Starpower +36.58%
#4 Pons Pons +34.90%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.72%
#6 aelf aelf +20.67%
#7 SkyAI SkyAI +19.93%
#8 Ocean Protocol Ocean Protocol +17.12%
#9 Mubarak Mubarak +16.27%
#10 Decred Decred +15.76%
Coin of the day
Bitway Bitway
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Kedudukan dalam Saham #29359
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Harga Saham
$0.365
Disegerakkan terakhir: 2025-08-01
Modal Pasaran
$21.54M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Elevation Oncology, Inc. (ELEV)

Kategori

Healthcare
Sejarah hasil dividen untuk Elevation Oncology, Inc. (ELEV)
Hasil dividen (TTM) bagi Elevation Oncology, Inc. (simbol saham: ELEV) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Elevation Oncology, Inc. (ELEV) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH